Poor returns disappoint ATP critics
ATP should have done better in the first half of 2023, say two well-known ATP critics, who point to poor returns on equities, partly due to last year’s Novo Nordisk sell-off.
It’s hard to find any jubilant faces over the latest returns from the Danish state pension fund.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
Get full access for you and your coworkers
Start a free company trial todayRelated articles
ATP’s investment portfolio yielded a negative return in Q2
For subscribers
ATP rejects new criticism of its investment model
For subscribers
